Restricted accessResearch articleFirst published online 1992-2
Bilateral Breast Involvement in A 71-Year-Old White Man with Lambda Light Chain Disease. Regression after A new Chemotherapy Combination. A Case Report
A rare case of lambda light chain disease with bilateral breast involvement is described. A complete regression after a new chemotherapy combination (peptichemio + teniposide + dexa-methasone) was obtained. A previous treatment with prednisone + melphalan was ineffective.
Get full access to this article
View all access options for this article.
References
1.
BatailleR., JacquesS.: Solitary myeloma, clinical and prognostic features of a review of 114 cases.Cancer, 48: 845–851, 1981.
2.
DerelliE., DonatiE., MartinazzoliF., PasiniC., SavioE.: Contributo del laboratorio alla diagnosi di mieloma micromolecolare.Quad. Sclavo Diagn., 20: 171–180, 1984.
3.
LargeD.M., JonesJ.M., ShaletS.M., ScraffeJ.M., GibbsA.C.C.: Gynaecomastia complicating the treatment of myeloma.Br. J. Cancer, 48: 69–74, 1983.
4.
MediniE., RaoY., LevittS.: Solitary extramedullary plasmacytoma of the upper respiratory and digestive tracts.Cancer, 45: 2893–2896, 1980.
5.
MerinoM.J.: Plasmacytoma of the breast.Arch. Pathol. Lab. Med., 108: 676–678, 1984.
6.
ProctorN.S.F., RippeyJ.J., ShulmanG., CohenC.: Extra-medullary plasmacytoma of the breast.J. Pathol., 116: 97–100, 1975.
7.
RosembergB., AltieJ., MandelbaumH.: Breast tumor as the presenting sign of multiple myeloma.N. Engl. J. Med., 269: 359–361, 1963.
8.
ShaletS.M.: Effects of chemotherapy on gonadal function of patients.Cancer Treat. Rev., 7: 141–152, 1980.
9.
ZaniboniA., SimonciniE., MarpicatiP., MontiniE., RossiG., MariniG.: Peptichemio, teniposide and high-dose dexamethasone: a new active combination for relapsing and refractary multiple myeloma. A pilot study.Anticancer Res., 8: 125–128, 1988.
